COVID's Silver Lining; 'I Could Kill Someone'; Measles or MMR Detection?

Note that some links may require registration or subscription.

The COVID-19 pandemic has a scientific silver lining: a rare opportunity to watch our immune system develop defenses against a novel pathogen in real time. (STAT)

Mpox cases in the U.S. are currently twice as high as they were this time last year, CDC data show. (CNN)

Pharmaceutical firm WuXi AppTec allegedly shared U.S. intellectual property with Chinese authorities without consent, according to intelligence officials. (Reuters)

Two-thirds of U.S. babies with sickle cell disease are born in counties with high or very high social vulnerability, CDC researchers detailed in Morbidity and Mortality Weekly Report (MMWR).

Who can sue the FDA? Supreme Court Justice Samuel Alito's question has implications beyond only the current mifepristone case. (STAT)

Grieving? Watch your step -- your balance and other capabilities could be impaired. (NPR)

The robot is in: AI-powered robots are offering preventive medicine screenings and reminding older adults to take their medications. (New York Post)

"I could kill someone": U.S. troops need more sleep, according to a report from the Government Accountability Office. (Washington Times)

Is it time to implement indoor air quality standards? These scientists think so. (Science)

The Centers for Medicare & Medicaid Services did not ensure that selected states complied with Medicaid managed care mental health and substance use disorder parity requirements, said an HHS Office of Inspector General report.

Meanwhile, new federal rules aimed at ensuring continued health coverage for low-income children are creating tensions with Florida. (Tampa Bay Times)

For people with aphantasia, memories may not be visual. (CNN)

A survey from the American Nurses Foundation found that nurses at all career levels desire more mentorship opportunities.

Syndromic panels that test for multiple causes of rash may incorrectly indicate measles in children recently vaccinated with the measles, mumps, and rubella vaccine. (MMWR)

The FDA expanded the indication for tenofovir alafenamide (Vemlidy) to treat chronic hepatitis B virus infection to include pediatric patients 6 years and older, drugmaker Gilead announced.

Meanwhile, Bristol Myers Squibb said a phase III trial of ozanimod (Zeposia) for moderate-to-severe active Crohn's disease failed to meet its primary goal.

And Amneal Pharmaceuticals is voluntarily recalling certain lots of vancomycin hydrochloride due to the potential for over-potent bottles that pose a risk to patients, the FDA announced.

Self-proclaimed "mean old dog walker," Ron Louie, MD, said a dog helped diagnose his cancer. (JAMA Oncology)

Human milk has vast benefits for infants. Researchers are looking to harness its power for adults. (STAT)

Potentially the worst dengue outbreak in the Americas to date has arrived, with Brazil, Argentina, and Paraguay being hardest hit. (Reuters)

Comment